PC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection.

Kraft, Anke R M

PC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection. [electronic resource] - Journal of virology Dec 2013 - 12636-47 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1098-5514

10.1128/JVI.00936-13 doi


Animals
Antibodies, Monoclonal--administration & dosage
Humans
Interleukin-10--immunology
Lung--drug effects
Lymphocytic Choriomeningitis--drug therapy
Lymphocytic choriomeningitis virus--genetics
Male
Mice
Mice, Inbred C57BL
T-Lymphocytes, Regulatory--drug effects